Publications - Page 2

Page : [ 1 2 3 ] : Prev : Next

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.

British Journal of Cancer 113, pages 1027-1034, 29 September 2015.
DOI: 10.1038/bjc.2015.329

Diether Lambrechts, Bernard Thienpont, Vincent Thuillier, Xavier Sagaert, Matthieu Moisse, Gilian Peuteman, Carles Pericay, Gunnar Folprecht, John Zalcberg, Chiara Zilocchi, Emmanuelle Margherini, Marielle Chiron and Eric Van Cutsem


» read more

 

Reduced rate of copy number aberrations in mucinous colorectal carcinoma

Oncotarget Vol. 6:28 pages 25715-25725, 21 September 2015
DOI: 10.18632/oncotarget.4706

Niek Hugen, Femke Simmer, Leonie J.M. Mekenkamp, Miriam Koopman, Evert van den Broek, Johannes H.W. de Wilt, Cornelis J.A. Punt, Bauke Ylstra, Gerrit A. Meijer, Iris D. Nagtegaal.

» read more

 

Biomarker-driven Studies in Metastatic Colorectal Cancer (mCRC): Challenges and Opportunities

The Journal of OncoPathology, Vol 2:4, pages 37-45(9). November 2014
DOI: 10.13032/tjop.2052-5931.100113.

Van Cutsem, Eric; Prager, Gerald; Sargent, Daniel; Byrne, Annette T.; Huber, Heinrich J.; Middleton, Gary; Khan, Khurum; De Mattos-Arruda, Leticia; Seufferlein, Thomas.


» read more

 

Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy

Angiogenesis, Vol 17:4, pages 909-920. October 2014
DOI: 10.1007/s10456-014-9438-1

Sanne de Haas, Paul Delmar, Aruna T. Bansal, Matthieu Moisse, David W. Miles, Natasha Leighl, Bernard Escudier, Eric Van Cutsem, Peter Carmeliet, Stefan J. Scherer, Celine Pallaud, Diether Lambrechts.


» read more

 

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

Genome Research, 24:12 pages 2022-2032, 18 September 2014.
DOI: 10.1101/gr.175141.114

Ilari Scheinin, Daoud Sie, Henrik Bengtsson, Mark A. van de Wiel, Adam B. Olshen, Hinke F. van Thuijl, Hendrik F. van Essen, Paul P. Eijk, François Rustenburg, Gerrit A. Meijer, Jaap C. Reijneveld, Pieter Wesseling, Daniel Pinkel, Donna G. Albertson and Bauke Ylstra.


» read more

 

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

Cancer Discovery 4:9 Pages 998-1013. 15 September 2014.
DOI: 10.1158/2159-8290.CD-14-0001

Manuel Hidalgo, Frederic Amant, Andrew V. Biankin, Eva Budinská, Annette T. Byrne, Carlos Caldas, Robert B. Clarke, Steven de Jong, Jos Jonkers, Gunhild Mari Mælandsmo, Sergio Roman-Roman, Joan Seoane, Livio Trusolino, Alberto Villanueva.


» read more

 

Bevacizumab in the treatment of metastatic colorectal cancer - a retrospective analysis with a focus on the elderly.

Z Gastroenterol 52 - KG171, August 2014.
DOI: 10.1055/s-0034-1386193

J Betge, T Zhan, S Belle, N Härtel, T Hielscher, RD Hofheinz, MP Ebert, N Schulte.


» read more

 

Validation of an imageable surgical resection animal model of Glioblastoma (GBM)

Journal of Neuroscience Methods Vol 233, Pages 99–104, 15 August 2014
DOI: 10.1016/j.jneumeth.2014.05.006

Sweeney KJ, Jarzabek MA, Dicker P, O'Brien DF, Callanan JJ, Byrne AT, Prehn JH.


» read more

 

Genetic markers of bevacizumab-induced hypertension

Angiogenesis, Vol 17:3, p 685-694. July 2014.
DOI: 10.1007/s10456-014-9424-7

Diether Lambrechts, Matthieu Moisse, Paul Delmar, David W. Miles, Natasha Leighl, Bernard Escudier, Eric Van Cutsem, Aruna T. Bansal, Peter Carmeliet, Stefan J. Scherer, Sanne de Haas, Celine Pallaud.


» read more

 

Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.

Drug Discovery Today Vol 18: 21–22, Pages 1052–1066, November 2013
DOI: 10.1016/j.drudis.2013.06.004

Jarzabek MA, Sweeney KJ, Evans RL, Jacobs AH, Stupp R, O'Brien D, Berger MS, Prehn JH, Byrne AT.


» read more

 
Page : [ 1 2 3 ] : Prev : Next